1. Home
  2. Analysis
  3. Levetiracetam
  4. Intervertebral-disc-space-narrowing

Levetiracetam and Intervertebral disc space narrowing - a phase IV clinical study of FDA data

Summary:

Intervertebral disc space narrowing is reported as a side effect among people who take Levetiracetam (levetiracetam), especially for people who are female, 60+ old, also take Acetaminophen, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Intervertebral disc space narrowing when taking Levetiracetam. It is created by eHealthMe based on reports of 74,747 people who have side effects when taking Levetiracetam from the FDA, and is updated regularly.

What is Levetiracetam?

Levetiracetam has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 75,294 Levetiracetam users. Check the latest studies of Levetiracetam.

What is Intervertebral disc space narrowing?

Intervertebral disc space narrowing (spinal disc space narrowing) is found to be associated with 451 drugs and 316 conditions by eHealthMe. Check the latest studies of Intervertebral disc space narrowing.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

74,747 people reported to have side effects when taking Levetiracetam.
Among them, 11 people (0.01%) have Intervertebral disc space narrowing.

Could Levetiracetam cause Intervertebral disc space narrowing?

Among these 11 people:

What is the gender of people who have Intervertebral disc space narrowing when taking Levetiracetam? *

  • female: 72.73 %
  • male: 27.27 %

What is the age of people who have Intervertebral disc space narrowing when taking Levetiracetam? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 11.11 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 88.89 %

What are other drugs people take besides Levetiracetam? *

  1. Zometa: 9 people, 81.82%
  2. Acetaminophen: 9 people, 81.82%
  3. Colestid: 8 people, 72.73%
  4. Megace: 8 people, 72.73%
  5. Lisinopril: 8 people, 72.73%
  6. Lexapro: 8 people, 72.73%
  7. Lantus: 8 people, 72.73%
  8. Keppra: 8 people, 72.73%
  9. Humalog: 8 people, 72.73%
  10. Glycolax: 8 people, 72.73%

What are other side effects people have besides Intervertebral disc space narrowing? *

  1. Osteopenia (a condition where bone mineral density is lower than normal): 10 people, 90.91%
  2. High Blood Pressure: 9 people, 81.82%
  3. Cataract (clouding of the lens inside the eye): 9 people, 81.82%
  4. Osteolysis (dissolution of bone): 9 people, 81.82%
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 9 people, 81.82%
  6. Neuropathy Peripheral (surface nerve damage): 9 people, 81.82%
  7. Back Pain: 9 people, 81.82%
  8. Bone Disorder: 9 people, 81.82%
  9. Multiple Myeloma (cancer of the plasma cells): 9 people, 81.82%
  10. Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 9 people, 81.82%

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 9 people, 81.82%
  2. Stress And Anxiety: 1 person, 9.09%
  3. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 9.09%
  4. Pain: 1 person, 9.09%
  5. Nausea And Vomiting: 1 person, 9.09%
  6. Nausea (feeling of having an urge to vomit): 1 person, 9.09%
  7. Metastases To Central Nervous System (cancer spreads to central nervous system): 1 person, 9.09%
  8. Lung Cancer Metastatic (lung cancer spreads to other parts): 1 person, 9.09%
  9. Lung Adenocarcinoma (a form of non-small cell lung cancer): 1 person, 9.09%
  10. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Levetiracetam and have Intervertebral disc space narrowing?

- Check whether Intervertebral disc space narrowing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levetiracetam:

Intervertebral disc space narrowing treatments and more:

How severe was Intervertebral disc space narrowing and when was it recovered:

Expand to all the drugs that have ingredients of levetiracetam:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levetiracetam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intervertebral disc space narrowing:

Browse all the conditions that are associated with Intervertebral disc space narrowing:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam (the active ingredients of Levetiracetam) and Levetiracetam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.